MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/cre2.589

Медицинская библиотека · Clinical and experimental dental research · 2022

Validation of a noninvasive aMMP-8 point-of-care diagnostic methodology in COVID-19 patients with periodontal disease.

Gupta Shipra, Mohindra Ritin, Singla Mohita, Khera Sagar, Kumar Amit, Rathnayake Nilminie, Sorsa Timo, Pfützner Andreas, Räisänen Ismo T, Soni Roop K, Kanta Poonam, Jain Akanksha, Gauba Krishan, Goyal Kapil, Singh Mini P, Ghosh Arnab, Kajal Kamal, Mahajan Varun, Suri Vikas, Bhalla Ashish

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

OBJECTIVES

The aim of this study was to validate an active matrix metalloproteinase (MMP-8) point-of-care diagnostic tool in COVID-19 patients with periodontal disease.

SUBJECTS, MATERIALS, AND

METHODS

Seventy-two COVID-19-positive and 30 COVID-19-negative subjects were enrolled in the study. Demographic data were recorded, periodontal examination carried out, and chairside tests run for evaluating the expression of active MMP-8 (aMMP-8) in the site with maximum periodontal breakdown via gingival crevicular fluid sampling as well as via a mouth rinse-based kit for general disease activity. In COVID-19-positive patients, the kits were run again once the patients turned COVID-19 negative.

RESULTS

The overall (n = 102) sensitivity/specificity of the mouthrinse-based kits to detect periodontal disease was 79.41%/36.76% and that of site-specific kits was 64.71%/55.88% while adjusting for age, gender, and smoking status increased the sensitivity and specificity (82.35%/76.47% and 73.53%/88.24, respectively). Receiver operating characteristic (ROC) analysis for the adjusted model revealed very good area under the ROC curve 0.746-0.869 (p < .001) and 0.740-0.872 (p < .001) (the aMMP-8 mouth rinse and site-specific kits, respectively). No statistically significant difference was observed in the distribution of results of aMMP-8 mouth rinse test (p = .302) and aMMP-8 site-specific test (p = .189) once the subjects recovered from COVID-19.

CONCLUSIONS

The findings of the present study support the aMMP-8 point-of-care testing (PoCT) kits as screening tools for periodontitis in COVID-19 patients. The overall screening accuracy can be further increased by utilizing adjunctively risk factors of periodontitis. The reported noninvasive, user-friendly, and objective PoCT diagnostic methodology may provide a way of stratifying risk groups, deciding upon referrals, and in the institution of diligent oral hygiene regimens.

Для цитирования: Gupta Shipra, Mohindra Ritin, Singla Mohita, Khera Sagar, Kumar Amit, Rathnayake Nilminie, Sorsa Timo, Pfützner Andreas, Räisänen Ismo T, Soni Roop K, Kanta Poonam, Jain Akanksha, Gauba Krishan, Goyal Kapil, Singh Mini P, Ghosh Arnab, Kajal Kamal, Mahajan Varun, Suri Vikas, Bhalla Ashish. Validation of a noninvasive aMMP-8 point-of-care diagnostic methodology in COVID-19 patients with periodontal disease.. Clinical and experimental dental research. 2022. DOI: 10.1002/cre2.589.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.